DC's Clayface has quietly achieved a significant box-office milestone, crossing the $100 million mark globally just two weeks into its theatrical run. The film, which cost a modest $40 million to produce, has now broken even theatrically—a rare feat in today's superhero landscape, where big-budget spectacles often struggle to turn a profit on the big screen alone.
While Clayface isn't pulling in the kind of numbers that rival the genre's heavy hitters, its performance is still noteworthy. The movie is on track to surpass this year's Supergirl, which ended its run with around $125 million worldwide but carried a production budget nearly four times larger. That contrast highlights the cost-effective approach DC Studios is taking with its more character-driven projects.
At $40 million, Clayface sits comfortably in the mid-range of recent horror budgets. It cost less than Scream 7 ($45 million) and Resident Evil ($75 million), but it's a far cry from the ultra-low-budget anomalies like Backrooms ($10 million) and Obsession ($1 million), which together grossed nearly $1 billion worldwide. The film's financial model echoes the template set by 2019's Joker, which earned over $1 billion against a $55 million budget—though Joker was clearly an outlier.
In its third weekend, Clayface added roughly $7 million domestically, pushing its North American total to nearly $60 million. That's enough to surpass director James Watkins' previous horror hit, Speak No Evil ($77 million worldwide), and it's on pace to overtake his 2012 film The Woman in Black ($130 million worldwide). The movie's steady performance comes even as Warner Bros. trimmed its theater count by 532 locations, a standard move for a film entering its third week.
Set in an alternate Gotham City from Matt Reeves' The Batman, Clayface stars Tom Rhys Harries, Naomi Ackie, Max Minghella, and Eddie Marsan. The film's standalone nature allows DC Studios to explore Batman's rogues' gallery without the burden of a shared universe, a strategy that's paying off both critically and commercially.
Critics and audiences have responded positively, with the film holding a "Certified Fresh" 78% score on Rotten Tomatoes. The consensus praises its unique identity within the DCU, noting that it "takes time to get going until it eventually morphs into an icky and satisfying revenge thriller." For fans of body horror and character-driven storytelling, Clayface is proving to be a welcome surprise.
As the film continues its run, it's clear that DC's gamble on a lower-budget, horror-inflected approach is resonating. Whether it can sustain momentum in the coming weeks remains to be seen, but for now, Clayface is a testament to the viability of smart, cost-conscious filmmaking in the superhero genre.
